About
Jade Biosciences, Inc is a clinical-stage biopharmaceutical company developing therapies targeting autoimmune diseases, with a lead candidate focused on treating immunoglobulin A nephropathy by inhibiting the cytokine APRIL.
Explore Jade Biosciences, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.